Better Knowledge about Testicular Cancer Might Improve the Rate of Testicular (Self-)Examination: A Survey among 1,025 Medical Students in Germany
- PMID: 35901778
- PMCID: PMC9677845
- DOI: 10.1159/000525854
Better Knowledge about Testicular Cancer Might Improve the Rate of Testicular (Self-)Examination: A Survey among 1,025 Medical Students in Germany
Abstract
Introduction: Testicular cancer (TC) is the most common malignancy among young men. Public awareness of the disease and testicular (self-)examination (TSE) is low. This study aims to evaluate the awareness of German medical students on TC.
Methods: A 25-item questionnaire on TC was handed out during a medical student's football tournament in Germany. Data collection was anonymous.
Results: Questionnaires were answered by 573 (56%) female and 452 (44%) male medical students. Most students had gaps in their knowledge about TC: 483 (48%) students knew, the most common age at which TC occurs, and 413 (41%) knew its cure rate. Having dealt with TC during their studies was significantly associated with a better knowledge about TC (p = 0.001). These students also had a higher rate of TSE among male students (66% vs. 52%, p = 0.002). This also applies to examining the partner's testicles by female students (25% vs. 13%, p < 0.001).
Conclusion: Even in a positively selected collective like medical students, the knowledge about TC is low. Better knowledge might improve the chance of detecting the disease early. Therefore, our joint project of urologists, patients, and supporters called Prevention and Advocacy of Testicular Education e.V. (PATE) works on rising public TC awareness in Germany.
Keywords: Awareness; Germany; Medical students; Testicular cancer; Testicular self-examination.
© 2022 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
Dr. Huber reports grants and nonfinancial support from Intuitive Surgical, Takeda, Janssen, and Coloplast outside the submitted work. Moreover, he is managing director of the Urological Foundation for Health. All other authors declare that there is no conflict of interest.
References
-
- Bertz J, Buttmann-Schweiger N, Kraywinkel K. Epidemiologie bösartiger hodentumoren in deutschland. Der Onkologe. 2017;23((2)):90–96.
-
- Germà-Lluch JR, Garcia del Muro X, Maroto P, Paz-Ares L, Arranz JA, Gumà J, et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG) Eur Urol. 2002;42((6)):553–563. discussion 62–3. - PubMed
-
- Kier MG, Lauritsen J, Mortensen MS, Bandak M, Andersen KK, Hansen MK, et al. Prognostic factors and treatment results after bleomycin, etoposide, and cisplatin in germ cell cancer: a population-based study. Eur Urol. 2017;71((2)):290–298. - PubMed
-
- Kollmannsberger C, Tandstad T, Bedard PL, Cohn-Cedermark G, Chung PW, Jewett MA, et al. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol. 2015;33((1)):51–57. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
